Pharmacyclics - Ownership and Business Overview

Life ScienceCompany

Pharmacyclics Ownership

Who owns Pharmacyclics?

Pharmacyclics is owned by AbbVie. It was acquired on March 4, 2015.

Was Pharmacyclics formerly PE-backed?

Yes. Pharmacyclics was formerly owned by 1 private investor.

Pharmacyclics Business Overview

Where is Pharmacyclics headquartered?

Pharmacyclics is headquartered in Sunnyvale, California.

How many employees does Pharmacyclics have?

Pharmacyclics has 600 employees.

What sector is Pharmacyclics in?

Pharmacyclics is a life science company.

When was Pharmacyclics founded?

Pharmacyclics was founded in 1991.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Pharmacyclics, Inc.

999 East Arques Avenue,
Sunnyvale, California 94085
United States,
(408) 774-0330
www.pharmacyclics.com

Pharmacyclics, Inc. is a biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.


 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.